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Purpose: To investigate the optical coherence tomographic (OCT) patterns and long-term surgical
outcomes of patients with vitreomacular traction syndrome (VMT).
Methods: From May 2002 to April 2008, patients with OCT-conﬁrmed VMT who underwent vitrectomy
were retrospectively reviewed. Complete pre- and postoperative ophthalmic and OCT examinations were
recorded. All cases were followed for at least 2 years. The OCT patterns of VMT were classiﬁed into two
groups: Group 1, V-shaped macular traction (1A: without macular detachment, 1B: with macular
detachment); Group 2, U-shaped macular traction (2A: without macular detachment, 2B: with macular
detachment). Multiple linear regression analysis of selective factors was performed to investigate the
main determinants of visual improvement.
Results: Twenty-ﬁve eyes of 25 consecutive patients were enrolled (8 in 1A, 6 in 1B, 6 in 2A, 5 in 2B). One
patient in 2A progressed to 2B within 4 months. After surgery, 18 patients regained normal foveal
contour accompanied by visual improvement; three patients had persistent cystoid macular edema
throughout the follow-up period and a worsened visual acuity; the other four had an unchanged visual
status despite improved foveal conﬁguration. The mean  standard deviation thickness in the central
macular area was 632.0  228.3 mm preoperatively and347.1  126.1 mm postoperatively (p < 0.001).
Multiple lineal regression analysis revealed that U-shape VMT (p ¼ 0.005), preoperative foveal
detachment (p ¼ 0.011) and preoperative visual acuity (p ¼ 0.035) might correlate with ﬁnal vision.
Conclusion: OCT may detect two major conﬁgurations of VMT. Vitrectomy is an effective treatment, but
U-shaped macular traction, preoperative foveal detachment and poor preoperative vision show
unfavorable visual prognosis.
Copyright  2013, The Ophthalmologic Society of Taiwan. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Vitreomacular traction syndrome (VMT) is characterized by an
incomplete vitreous detachment with persistent vitreous traction
on the macular area leading to capillary leakage, macular folding,
increased macular thickness, cystoid macular edema, or even
retinal detachment. Central vision may be affected signiﬁcantly.1,2
Although spontaneous detachment of the vitreous traction from
the macula with resolution of macular edema and improvement inology, National Taiwan Uni-
n University, 7, Chung-Shan
ually to this article.
e Ophthalmologic Society of Taiwvisual acuity (VA) has been reported,3 vitrectomy is still the
mainstay treatment of VMT that removing the vitreous traction in
order to obtain visual improvement is necessary inmost cases.2,4e10
Optical coherence tomography (OCT) is a noninvasive imaging
technique that has been used extensively for the diagnosis and
follow-up of a variety of macular diseases. Its ability of obtaining
high resolution images of the vitreoretinal interface greatly facili-
tates treatment decision and presurgical planning.11e14
Although surgical results of VMT have been reported in the lit-
erature,2,14e16 there are few results of long-term follow-up. In
addition, the association of OCT ﬁndings and visual prognosis has
not beenwell studied. The purpose of this studywas to examine the
patterns of OCT changes in VMT, and to determine the relationships
between OCT changes and long-term anatomical and functional
surgical outcomes.an. Published by Elsevier Taiwan LLC. All rights reserved.
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From May 2002 to April 2008, all charts of patients who un-
derwent vitrectomy for VMTat National Taiwan University Hospital
were carefully reviewed. All patients with a follow-up period of <2
years as well as those with myopic retinopathy, proliferative ret-
inopathy, ocular inﬂammation, retinal tears, or retinal detachment
and retinal vascular diseases were excluded.
The diagnosis of VMT was tentatively made by biomicroscopic
ﬁndings, which showed an epimacular membrane and elevated
retina with a partially detached vitreous cortex, and further con-
ﬁrmed by OCT demonstrated an apparent traction from the vitre-
ous causing morphologic increased thickness of the central macula.
Detailed preoperative and postoperative ophthalmic examination
results of each case were recorded including best-corrected Snellen
VA (BCVA), biomicroscopy, color fundus photography, and OCT
analysis (STRATUS OCT; Carl Zeiss Meditec, Inc., Jena, Germany).
OCT should be performed within 1 month before surgery. The pe-
riods between the onset of subjective symptoms and time of vit-
reous surgery were also recorded. OCT and BCVA examinationwere
recorded 4e6 months after surgery and followed every 6 months.
An experienced OCT technician performed all OCT. OCT images
were generated by using the fast macular scan mode (6 radial lines
oriented 30 from one another centered on the fovea) according to
the manufacturer’s protocol. The OCT software for retinal mapping
calculated the mean retinal thickness in nine areas. Only the most
central area of 1 mm in diameter with the fovea in the centre was
used for mean fovea thickness calculations.
According to the OCT ﬁndings, the VMT syndromewas classiﬁed
into two groups by the pattern of vitreouseretinal adhesion; both
groups could be further divided into two subtypes according to
retinal detachment: Group 1, V-shaped macular traction without
(1A, Fig. 1A) or with (1B, Fig. 1B) macular detachment. Group 2, OCT
revealed U-shaped macular traction (which had broader vitreouse
retinal adhesion) without (2A, Fig. 1C) or with (2B, Fig. 1D) macular
detachment.
The surgeries were performed by four surgeons (J.S. Huang, C.M.
Yang, C.H. Yang, and T.C. Ho). All performed the same surgical
principles as follows: standard three-port 20-gauge pars plana
vitrectomy set-up was used for all cases in this study. After core
vitrectomy, triamcinolone acetonide (TA)-assisted anteriore
posterior vitreous traction was removed as completely and safely
as possible. Adherent posterior cortical vitreouswas removed either
by direct suction from the vitrector or by forceps peeling. AllFig. 1. (A) Group 1A, V-shaped macular traction without detachment. (B) Group 1B, V-shap
without retinal detachment. (D) Group 2B, U-shaped macular traction with traction detachepiretinal membranes were removed but internal limiting mem-
branes (ILM) were not intentionally removed. If signiﬁcant retinal
wrinkles were found during operation, intravitreal gas infusionwas
performed at the end of surgery as individual surgeon’s discretion.
This retrospective study was approved by the Ethics committee/
Institutional Review Board of the National Taiwan University
Hospital.
The Snellen VA was converted to the logarithm of the minimal
angle of resolution (log MAR) units prior to descriptive statistical
analysis. An increase in BCVA of at least 3 lines was deﬁned as
vision improvement. VA and OCT ﬁndings were obtained within 1
month before operation; 4e6 months, 1 year, 1.5 years, and 2 years
after operation. For statistical analysis the Student paired t test
was used as appropriate. To examine the differences among
Groups 1 and 2, statistical analysis of noncontinuous variables
were performed with Chi-square test or Fisher’s exact test. Con-
tinuous variables are presented as mean  standard deviation and
ManneWhitney test was performed to make comparisons
between Groups 1 and 2. Multiple lineal regression analysis was
also performed to ﬁnd out possible factors associated with VA
improvement. Factors for regression analysis included age, sex,
type of vitreouseretinal adhesion, foveal detachment, post-
operative central foveal thickness, duration of symptoms
(months), and intravitreal gas tamponade. A p value <0.05 was
considered statistically signiﬁcant.
3. Results
There were 25 eyes of 25 patients enrolled in this study. Four-
teen women and 11 men were included with mean age 60.7  15.0
years (range, 26e89 years). The period between the onset of sub-
jective symptoms and vitreous surgery was 3.3  2.5 months
(range, 0.5e12 months). All patients were followed at least for 2
years. The baseline features of patients are shown in Table 1.
According to the OCT ﬁndings, there were eight cases in Group
1A and six cases in 1B. Group 2A enrolled six cases and 2B had ﬁve
cases. However, one case initially manifested with the features of
Group 2A progressed to Type 2B within 4 months, which was
associated with deteriorated VA. No case had macular holes
detected by OCT before and after surgery.
The preoperative VA was 1.1  0.4 log MAR and meta-
morphopsia presented in all cases. Themean ﬁnal postoperative VA
was 0.8  0.4 log MAR (p ¼ 0.002) and three cases still had
metamorphopsia. Eighteen patients (72.0%) showed improvemented macular traction with retinal detachment. (C) Group 2A, U-shaped macular traction
ment.
Table 1





























1 57 F Left 1A 251 224 1.30 0.52 þ/ SF6 36 1.5
2 89 M Right 1A 510 385 1.52 1.30 þ/ SF6 24 1
3 72 F Right 1A 924 199 2.00 1.30 þ/ SF6 32 2.5
4 70 F Left 1A 272 198 1.00 0.22 þ/ SF6 50 12
5 42 F Right 1A 634 316 0.70 0.30 þ/ None 48 0.5
6 55 M Left 1A 448 312 1.00 0.20 þ/ None 28 1.5
7 48 F Right 1A 521 235 0.70 0.20 þ/ SF6 25 2
8 63 F Left 1A 872 211 1.30 0.52 þ/ SF6 26 3
9 58 F Right 1B 748 217 1.00 0.70 þ/ SF6 28 6
10 60 M Left 1B 930 507 0.52 1.00 þ/þ None 34 2
11 75 M Right 1B 905 382 1.30 0.82 þ/ SF6 24 2
12 80 M Right 1B 609 407 0.82 0.82 þ/ None 40 3
13 52 M Left 1B 953 365 1.30 0.82 þ/ SF6 30 5
14 46 F Right 1B 896 401 1.00 0.70 þ/ SF6 26 4
15 45 M Left 2A 373 254 0.52 0.52 þ/ SF6 36 2
16 26 M Left 2A 364 327 1.30 1.00 þ/ None 40 1
17 61 F Right 2A 463 219 1.00 1.00 þ/ None 56 3
18 55 F Left 2A 522 462 1.00 0.52 þ/ None 28 3
19 65 M Right 2A 652 510 1.00 0.70 þ/ None 24 4
20 68 F Left 2A 631 496 1.30 1.00 þ/ SF6 26 2.5
21 86 M Left 2A/2B 291 310 1.40 1.00 / None 60 8
22 41 F Right 2B 550 335 0.52 1.30 þ/þ SF6 32 3
23 76 F Left 2B 809 214 2.00 1.52 þ/ SF6 26 2
24 71 M Left 2B 789 540 1.00 1.32 þ/þ SF6 25 2
25 56 F Right 2B 883 652 1.00 1.00 þ/ SF6 29 6
Grouping: 1A, V-shaped macular traction without detachment; 1B, V-shaped macular traction with retinal detachment; 2A, U-shaped macular traction without retinal
detachment;2B, U-shaped macular traction with traction detachment.
F ¼ female; Log MAR ¼ logarithm of minimum angle of resolution; M ¼ male; Pre-OP ¼ preoperative; post-OP ¼ postoperative.
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ness. However, four patients (16.0%) remained with unchanged
visual status and the other three patients (12.0%) had deteriorated
VA (Fig. 2).
The mean central retinal thickness in the macula (the 1 mm
central circle) was 632.0  228.3 mm (range, 251e930 mm) preop-
eratively and 347.1  126.1 mm (range, 198e652 mm) post-
operatively (p < 0.0001). Twenty-four of 25 (96.0%) patients
showed a reduction in the thickness of the macular area post-
operatively (Fig. 3).
A standard three-port pars plana vitrectomy without ﬂuideair
exchange was performed in nine patients during surgery. Six eyesFig. 2. Preoperative and postoperative visual acuity distribution. Eighteen patients
showed improvement in visual acuity after vitrectomy. Three patients deteriorated,
and the other four patients showed an unchanged status.had well re-established foveal dips and VA improvement after
surgery. Three patients showed improved macular depression
conﬁguration, but still had minimal macular edema in the ﬁrst 6
months. At 2 years of follow-up, the macular edema of the two
patients improved and they regained some degrees of VA, but the
other one had persistent subretinal ﬂuid accumulation and visual
deterioration at the end of follow-up. Other 16 eyes underwent
vitrectomy and ﬂuid-air exchange with gas. Fourteen of 16 eyes
manifested well attached fovea and gained VA improvement. Two
eyes showed improved macular conﬁguration 6 months after vit-
rectomy. However, one of the two eyes still manifested persistent
subretinal ﬂuid after 2 years follow-up. All of the 25 patients had
neither signs of persistent VMT during follow-up, norFig. 3. Preoperative and postoperative macular thickness distribution. Twenty-four of
25 (96%) patients showed a reduction in the thickness of the macular area
postoperatively.
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recurrent vitreoretinal traction or retinal detachment at the end of
follow-up. All of the patients had various degrees of cataract pro-
gression after vitrectomy. Ten of them underwent cataract surgery
during the 2-year follow-up period.
The results of multiple lineal regression analysis (Table 2)
revealed that U-shape VMT, the preoperative foveal detachment
and poor preoperative VA might bring unfavorable ﬁnal vision
(p ¼ 0.005, 0.011, and 0.035, respectively).4. Discussion
In this study, OCT was used to evaluate the anatomical changes
of VMT before and after surgery. Yamada et al suggested that the
speciﬁc pattern of OCT may predict surgical outcome.9 They had
reported two types of VMT. The ﬁrst type was incomplete vitreous
detachment nasally and temporally causing V-shaped VMT with
fovea detachment. The second type had persistent nasal attach-
ment with detachment temporal to the fovea. In their study, the
ﬁrst type had more favorable visual outcome, while in the second
type, prominent cystoid macular edema (CME) developed and
resulted in macular hole or macular atrophy postoperatively. In our
study, we also found this classiﬁcation to be useful in deﬁning the
structural changes in this disease. However, each group could be
further divided into two subgroups (A and B) according to fovea
detachment or not at the time of surgery and A type had better
visual improvement than B type. Although the broad adhesion type
(U-shape) traction had worse visual results, which were the same
as the observation of Yamada et al,9 only three cases had minimal
CME after 6 months, one had CME at end of follow-up and none had
macular hole. According to our results, chronic CME with broad
edema area and foveal detachment preoperatively might result in
poor visual prognosis, instead of postoperative prominent CME.
We observed one case of U-shaped vitreoretinal traction with-
out fovea detachment (Group 2A) progressing to fovea detachment
(Group 2B) associated with deteriorated VA within 4 months.
Yamada et al also reported one case of V-shaped vitreoretinal
traction without fovea detachment progressing to fovea detach-
ment before surgery.9 These incidents suggested that the VMT
syndrome is a dynamic progressive disease with persistent traction
force exerted on the macula. In addition, spontaneous resolution of
VMT syndromemay occur.3 Hikichi et al reported that 6 (11%) of 53
patients with VMT syndrome developed a complete spontaneous
posterior vitreous detachment during a period of 60 months fol-
low-up.17 However, spontaneous separation of vitreoretinal adhe-
sion is uncommon and requires a prolonged waiting period, and
surgical intervention to relieve vitreous traction was indicated in
most patients with obvious traction on the macula.
Smiddy et al reported visual improvement in 10 of 16 eyes
(63%)18; MacDonald et al obtained visual improvement in 15 of 20Table 2
Multiple lineal regression analysis for difference of log MAR visual acuity in patients
between preoperation and postoperation.
*Multiple lineal regression






(V-shaped ¼ 1; U-shaped ¼ 2)
0.37 (0.13e0.60) 0.005
Foveal detachment 0.33 (0.09e0.57) 0.011
PreOP VA (log MAR) 0.39 (0.03e0.75) 0.035
A p-value <0.05 was considered statistically signiﬁcant.
* Factors for multiple lineal regression analysis included age, type of vitreous-
retinal adhesion, foveal detachment, postoperative central foveal thickness, dura-
tion of symptoms (months) and with or without intravitreal gas tamponade at the
end of operation. Table only shows factors that were statistically signiﬁcant.eyes (75%)15; Yamada et al showed visual improvement in nine of
14 eyes (64%) in their report.9 In our long-term study, 18 of 25 eyes
(72.0%) showed visual improvement. The surgical outcome was
similar to previous studies with various follow-up periods. Fur-
thermore, we also found the grouping of VMT showed statistical
correlations with VA outcome, V-shape VMT and undetached fovea
led to more favorable visual outcomes. The vitreous tractional
tension force induced by U-shaped macular traction might be dis-
tributed beyond the border of the foveal region, leading to more
widespread CME and subretinal ﬂuid accumulation as opposed to
V-shaped traction in the central foveal region. However, fovea
detachment was also associated with unfavorable outcome in
either group. In our results, 11 eyes of VMT with foveal detachment
only six eyes (54.5%) had visual improvement. This limited visual
improvement might be due to chronic retinal detachment, CME,
and macular atrophy. Using OCT to evaluate VMT syndrome offers
ophthalmologists a valuable diagnostic tool for drawing up a ther-
apeutic plan and predicting visual prognosis.
Macular traction is frequently accompanied by increased retinal
thickness and cystoid changes in the sensory retina causing
decrease of vision and metamorphopsia. Hikichi et al reported that
43 of 53 eyes (81%) with VMT syndrome had cystoid macular
changes that persisted during a median follow-up period of 60
months in 67% of the eyes.17 Larsson et al reported that vitrectomy
effectively resolved traction in VMT syndrome, reduced retinal
thickness, and improved vision in all cases.2 Similar results were
found in our study. Twenty-four of 25 eyes had CME before surgery
and the mean central retinal thickness was 632.0  228.3 mm
preoperatively and 347.1126.1 mmat 2 years after surgery. All eyes
showed a reduction in the thickness of the macula postoperatively.
The difference was statistically signiﬁcant (p ¼ 0.002). Although
surgical intervention might effectively reduce central macular
thickness, postoperative macular thickness was not an indicator for
ﬁnal VA in our regress model. Preoperative prolonged CME could
result in retinal atrophy,18,19 and even the ﬁnal retinal thickness was
signiﬁcantly reduced but postoperative VA was still poor.
Complete releasing anterioreposterior traction force is the
mainstay treatment for VMT.20 Posterior vitreous cortex and hya-
loid membrane removal is the key point for releasing traction
force.15 In this study, all surgeons used TA-assisted vitrectomy to
remove anterioreposterior vitreous traction and epiretinal mem-
brane without ILM peeling. Reports from some studies demon-
strated that intraoperative use of TA during vitreoretinal surgery
improved visualization of the posterior hyaloid membrane, allow-
ing for improved surgical outcomes.21,22 Vitrectomy combine with
ILM peeling has been reported for treating VMT.10 The role of ILM
peeling for VMT is still controversial. It might further release the
traction force, prevent recurrent epiretinal membrane and help to
decrease macular edema.23,24
Our study has certain limitations. First, it is retrospective in
nature and surgeries were done by four surgeons in one hospital.
Although all surgeries were performed by four experienced sur-
geons, but they used the same surgical principles, the same in-
struments and identical procedures to treat the patients. Second,
only a small number of cases were included in the study. However,
all cases were followed for at least 2 years, and data from this long-
term study might be valuable. Our small study shows that vitrec-
tomy may effectively resolve traction in VMT, reduce retinal
thickness measured by OCT, and signiﬁcantly improving VA. The
effects may be maintained for a long period of time. U or V-shaped
macular traction, foveal detachment and preoperative VA seem to
be important factors affecting the visual outcome in VMT syn-
drome. Further studies with prospective design and with a larger
case number may be necessary to conﬁrm the efﬁcacy and prog-
nostic factors in the surgical treatment of this disease.
H.-W. Huang et al. / Taiwan Journal of Ophthalmology 3 (2013) 26e3030References
1. Smiddy WE, Green WR, Michels RG, de la Cruz Z. Ultrastructural studies of
vitreomacular traction syndrome. Am J Ophthalmol 1989;107:177e85.
2. Larsson J. Vitrectomy in vitreomacular traction syndrome evaluated by ocular
coherence tomography (OCT) retinal mapping. Acta Ophthalmol Scand 2004;82:
691e4.
3. Odrobina D, Michalewska Z, Michalewski J, Dziegielewski K, Nawrocki J. Long-
term evaluation of vitreomacular traction disorder in spectral-domain optical
coherence tomography. Retina 2011;31:324e31.
4. Cheng CL, Hoh ST, Chuan JC, Wong EY, Koh AH. Acute vitreomacular traction
with early spontaneous resolution. Clin Experiment Ophthalmol 2003;31:161e3.
5. Kusaka S, Saito Y, Okada AA, Sasamoto M, Hayashi A, Ohji M, et al. Optical
coherence tomography in spontaneously resolving vitreomacular traction
syndrome. Ophthalmologica 2001;215:139e41.
6. Levy J, Klemperer I, Belfair N, Rogozin A, Lifshitz T. Rapid spontaneous reso-
lution of vitreomacular traction syndrome documented by optical coherence
tomography. Int Ophthalmol 2004;25:247e51.
7. Munuera JM, García-Layana A, Maldonado MJ, Aliseda D, Moreno-Montañés J.
Optical coherence tomography in successful surgery of vitreomacular traction
syndrome. Arch Ophthalmol 1998;116:1388e9.
8. Uchino E, Uemura A, Doi N, Ohba N. Postsurgical evaluation of idiopathic vit-
reomacular traction syndrome by optical coherence tomography. Am J Oph-
thalmol 2001;132:122e3.
9. Yamada N, Kishi S. Tomographic features and surgical outcomes of vitre-
omacular traction syndrome. Am J Ophthalmol 2005;139:112e7.
10. Toklu Y, Demirel S, Sarac O, Cakmak HB, Cagil N. Anatomic and functional
outcome of triamcinolone-assisted 23-gauge vitrectomy in vitreomacular
traction syndrome. Semin Ophthalmol 2012;27:73e7.
11. Do DV, Cho M, Nguyen QD, Shah SM, Handa JT, Campochiaro PA, et al. Impact of
optical coherence tomography on surgical decision making for epiretinal
membranes and vitreomacular traction. Retina 2007;27:552e6.
12. Gallemore RP, Jumper JM, McCuen 2nd BW, Jaffe GJ, Postel EA, Toth CA.
Diagnosis of vitreoretinal adhesions in macular disease with optical coherence
tomography. Retina 2000;20:115e20.13. Stanga PE, Bird AC. Optical coherence tomography (OCT): principles of oper-
ation, technology, indications in vitreoretinal imaging and interpretation of
results. Int Ophthalmol 2001;23:191e7.
14. Sayegh RG, Georgopoulos M, Geitzenauer W, Simader C, Kiss C, Schmidt-
Erfurth U. High-resolution optical coherence tomography after surgery for
vitreomacular traction: a 2-year follow-up. Ophthalmology 2010;117. 2010e7,
2017.e1e2.
15. McDonald HR, Johnson RN, Schatz H. Surgical results in the vitreomacular
traction syndrome. Ophthalmology 1994;101:1397e403.
16. Massin P, Erginay A, Haouchine B, Paques M, Santiago PY, Than-Trong T, et al.
Results of surgery of vitreomacular traction syndromes. J Fr Ophtalmol
1997;20:539e47 [Article in French].
17. Hikichi T, Yoshida A, Trempe CL. Course of vitreomacular traction syndrome.
Am J Ophthalmol 1995;119:55e61.
18. Smiddy WE, Michels RG, Glaser BM, deBustros S. Vitrectomy for macular
traction caused by incomplete vitreous separation. Arch Ophthalmol 1988;106:
624e8.
19. Melberg NS, Williams DF, Balles MW, Jaffe GJ, Meredith TA, Sneed SR, et al.
Vitrectomy for vitreomacular traction syndrome with macular detachment.
Retina 1995;15:192e7.
20. Chung EJ, Lew YJ, Lee H, Koh HJ. OCT-guided hyaloid release for vitreomacular
traction syndrome. Korean J Ophthalmol 2008;22:169e73.
21. Sakamoto T, Miyazaki M, Hisatomi T, Nakamura T, Ueno A, Itaya K, et al. Tri-
amcinolone-assisted pars plana vitrectomy improves the surgical procedures
and decreases the postoperative blood-ocular barrier breakdown. Graefes Arch
Clin Exp Ophthalmol 2002;240:423e9.
22. Peyman GA, Cheema R, Conway MD, Fang T. Triamcinolone acetonide as an aid
to visualization of the vitreous and the posterior hyaloid during pars plana
vitrectomy. Retina 2000;20:554e5.
23. Dehghan MH, Salehipour M, Naghib J, Babaeian M, Karimi S, Yaseri M. Pars
plana vitrectomy with internal limiting membrane peeling for refractory
diffuse diabetic macular edema. J Ophthalmic Vis Res 2010;5:162e7.
24. Park DH, Kim IT. Long-term effects of vitrectomy and internal limiting mem-
brane peeling for macular edema secondary to central retinal vein occlusion
and hemiretinal vein occlusion. Retina 2010;30:117e24.
